Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals

British Journal of Dermatology

Volumn 152, Issue 1, 2005, Pages 122-129

  Harwood, Catherine A ^a   Perrett, C M ^a   Brown, V L ^a   Leigh, I M ^a   Mcgregor, J M ^a   Proby, C M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cutaneous warts; Human papillomavirus; Imiquimod; Immunosuppression; Organ transplantation

Indexed keywords

IMIQUIMOD; OPSITE; PLACEBO; POLYURETHAN; CREATININE; SALICYLIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; ERYTHEMA; FEMALE; HELPER CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RASH; RECURRENT DISEASE; RISK BENEFIT ANALYSIS; SIDE EFFECT; SKIN DISEASE; SKIN MANIFESTATION; T LYMPHOCYTE ACTIVATION; VERRUCA VULGARIS; WART VIRUS; CREATININE BLOOD LEVEL; CRYOTHERAPY; DISEASE SEVERITY; DRUG RESPONSE; EROSION; IMMUNOCOMPROMISED PATIENT; KIDNEY TRANSPLANTATION; TREATMENT RESPONSE;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AMINOQUINOLINES; ANTIVIRAL AGENTS; FEMALE; FOLLOW-UP STUDIES; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; IMMUNOCOMPROMISED HOST; INTERFERON INDUCERS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; SELF ADMINISTRATION; TREATMENT OUTCOME; WARTS;

EID: 13244270103     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06322.x     Document Type: Article

References (19)

1. Schmook T, Nindl I, Ulrich C et al. Viral warts in organ transplant recipients: new aspects in therapy. Br J Dermatol 2003; 149 (Suppl. 66): 20-4.
2. Harwood CA, Proby CM. Human papillomavirus infection in immunosuppression. In: Human Papillomaviruses: Clinical and Scientific Advances (Sterling JC, Trying SK, eds). London: Arnold, 2001: 102-17.
3. Pruvost C, Penso-Assathiany D, Bachot N et al. Risk factors for cutaneous wart onset in transplant recipients. Ann Dermatol Venereol 2002; 129:291-3.
4. Sequeira LA, Cutler RE. Occurrence of cancer in transplant recipients. Dialysis Transplant 1992; 21:143-51.
5. Dyall-Smith D, Trowell H, Mark A, Dyall-Smith M. Cutaneous squamous cell carcinomas and papillomaviruses in renal transplant recipients: a clinical and molecular biological study. J Dermatol Sci 1991; 2:139-46.
6. Leigh IM, Glover MT. Cutaneous warts and tumours in immunosuppressed patients. J R Soc Med 1995; 88:61-2.
7. Blessing K, McClaren KM, Benton EC et al. Histopathology of skin lesions in renal allograft recipients: an assessment of viral features and dysplasia. Histopathology 1989; 14:129-39.
8. Harwood CA, Proby CM. Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis 2002; 15:101-14.
9. Sander DN. Imiquimod: modes of action. Br J Dermatol 2003; 149 (Suppl. 660): 5-8.
10. Hemmi H, Kaisho T, Takeuchi O et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signalling pathway. Nat Immunol 2002; 3:196-200.
11. Beutner KR, Spruance SL, Hougham AJ et al. Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol 1998; 38:230-9.
12. Edwards L, Fernecy A, Eron L et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998; 134:25-30.
13. Tyring SK, Arany I, Stanley M et al. A randomized, controlled, molecular study of condyloma acuminata clearance during treatment with imiquimod. J Infect Dis 1998; 178:551-5.
14. Hengge UR, Esser S, Schultewolter T et al. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 2000; 143:1026-31.
15. Weisshaar E, Gollnick H. Potentiating effect of imiquimod in the treatment of verrucae vulgares in immunocompromised patients. Acta Derm Venereol 2000; 80:306-7.
16. Cutler K, Kagen MH, Don PC et al. Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus. Acta Derm Venereol 2000; 80:134-5.
17. Schwab RA, Elston DM. Topical imiquimod for recalcitrant facial flat warts. Cutis 2000; 65:160-2.
18. Hagman JH, Bianchi L, Marulli R et al. Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus. Clin Exp Dermatol 2003; 28:260-1.
19. Tyring S, Conant M, Marini M et al. Imiquimod; an international update on therapeutic uses in dermatology. Int J Dermatol 2002; 41:810-16.